ReviewFrontiers in oncology2021
Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China.
Anwen Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it